Sanolla (בת קול ד. אדלר)

Nesher, Israel

Cardiovascular Disease Diagnostics Medical Devices Pulmonary/ Asthma

Bat-Call Medical Device develops acoustic digital diagnostic systems. The company is initially focusing on chest acoustics to help with the early diagnosis and management of chronic diseases such as asthma, chronic obstructive pulmonary disease, heart failure, and pneumonia. Using body infrasound and deep-learning classification, Bat-Call Medical Device delivers valuable medical information with the aim of creating a fast, accurate, cost-effective, integrative healthcare system for hospitals and clinics. The company's CompuSteth device is able to detect, identify, and visually present inaudible sounds to physicians, making diagnosis faster and more precise without unnecessary CT or X-ray radiation exposure. The AIS is a portable device that captures chest sounds/infrasounds and uses deep-learning computerized classification of specific irregularities. The Spirome is an intuitive, reliable device that monitors chest functions, transmits the information to care providers, and enables patients to control and manage their chronic condition. The device is designed to help prevent seizures and reduce the amount of time spent in clinics and hospitals. The company's devices are currently awaiting FDA approval.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Sanolla (בת קול ד. אדלר) on @MedStartr Today #Asthma #COPD #HeartFailure #Pneumonia #CardiovascularDisease #Diagnostics #MedicalDevices #PulmonaryAsthma #MedMo #MedStartrVentures

https://www.medstartr.ai/s/ZRNq_bj5QGw

Get Involved in Sanolla (בת קול ד. אדלר)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2016
Website: sanolla.com/

Disease Areas

Asthma COPD Heart Failure Pneumonia

Technologies

Medical DevicesSensorsDiagnostics

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Sanolla (בת קול ד. אדלר)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.